Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany

Eur J Nucl Med. 2000 Oct;27(10):1465-72. doi: 10.1007/s002590000333.

Abstract

This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the "real-world" practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the year 1996. The study reveals considerable differences in actual practice concerning surgery and radioiodine treatment. The results indicate that consensus is lacking with respect to the multimodality treatment approach for differentiated thyroid carcinoma. Our analysis represents the most current and comprehensive national assessment of presenting patient characteristics, diagnostic tests, treatment and complications for thyroid cancer.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma, Follicular / diagnosis
  • Adenocarcinoma, Follicular / radiotherapy*
  • Carcinoma, Papillary / diagnosis
  • Carcinoma, Papillary / radiotherapy*
  • Data Collection
  • Female
  • Germany
  • Humans
  • Iodine Radioisotopes / adverse effects
  • Iodine Radioisotopes / therapeutic use*
  • Male
  • Middle Aged
  • Practice Patterns, Physicians'
  • Prospective Studies
  • Thyroid Neoplasms / diagnosis
  • Thyroid Neoplasms / radiotherapy*

Substances

  • Iodine Radioisotopes